Showing results (2801-2810 of 5,696) with videos related to
Sort By:
Pageof 570
Tumori|May 27, 2021
Guiding vacuum-assisted biopsy in prone position: digital breast tomosynthesis vs stereotacticGianfranco P Scaperrotta, Giulia Boffelli, Catherine Depretto, et al.Tumori|June 22, 2021
Improving outcomes of surgery in advanced infiltrative thymic tumours: the benefits of multidisciplinary approachAndrea Billè, Rajdeep Bilkhu, Giulia Benedetti, et al.Tumori|June 24, 2021
Hypoxia-induced RNASEH2A limits activation of cGAS-STING signaling in HCC and predicts poor prognosisFengbo Zhao, Aifen Liu, Xiu Gong, et al.Tumori|August 31, 1987
The role of combination cyclophosphamide, doxorubicin and cisplatin (CAP) chemotherapy in advanced non-small-cell lung cancerR Rosell Costa, A Abad-Esteve, J Roig Cutilles, et al.Tumori|January 7, 2023
TK-1, TP, Ang-2, and Tie-2 mRNA expression in plasma-derived microvesicles of chemo-refractory metastatic colorectal cancer patientsBeatrice Borelli, Stefania Crucitta, Alessandra Boccaccino, et al.Tumori|April 30, 1987
Intensive chemotherapy regimen in high-grade non Hodgkin's lymphomasP L Zinzani, F Gherlinzoni, F Lauria, et al.Tumori|April 30, 1987
Adjuvant treatment with melphalan in ovarian carcinoma with no residual disease following surgeryG Spatti, M Regazzoni, R Koronel, et al.Tumori|April 30, 1987
Intracavitary cisplatin in malignant cardiac tamponadeM Bindi, M Trusso, E TucciTumori|April 30, 1987
Carcinogenic effects of infantile and long-term 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment in the mouseG Della Porta, T A Dragani, G SozziTumori|November 30, 2022
A multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOINT trial (Meet-Uro trial 03)Giuseppe Procopio, Mélanie Claps, Chiara Pircher, et al.Pageof 570